Neonatal FeNO, risk factors, and respiratory morbidity in infants: A cohort study

Fanny E.M. Goth*, Birgitte J. Schmidt, Kent Green, Andreas K. Jensen, Lone Agertoft, Inger M. Jørgensen

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


Background: Respiratory symptoms in infancy are more common in premature infants. Nitric oxide (NO) is involved in prenatal and neonatal lung development. Measurement of exhaled NO is easy and well-tolerated by neonates. We investigated whether neonatal exhaled NO can be used to predict subsequent respiratory symptoms. Furthermore, we sought to determine prenatal and postnatal factors associated with increased respiratory symptom risk during the first year of life in premature and mature infants. Methods: Tidal fractional exhaled NO (FeNO) was measured in a birth cohort (n = 135) of premature and mature infants, up to six times during the first month of life. Primary outcomes were troublesome respiratory symptoms (TRS) and doctor-diagnosed asthmatic bronchitis (AB) at 1 year of age. Findings: The correlation between FeNO and TRS changed significantly in an age-dependent pattern in moderately premature infants (p =.02). Moderately premature infants with a low FeNO of 2 ppb on postnatal Day 3 had a 48% (95% confidence interval [CI]: 17%–80%) probability of TRS, compared with a probability of 12% (95% CI: 1%–64%) for otherwise similar infants with a FeNO of 11 ppb. Respiratory syncytial virus infection and parental smoking significantly increased the TRS risk in premature infants. Parental asthma and maternal antibiotic use during pregnancy significantly increased the TRS risk in mature infants. Interpretation: An age-specific association between neonatal FeNO and respiratory symptoms was seen in moderately premature infants. TRS risk was associated with postnatal factors in premature and prenatal factors in mature infants.

TidsskriftPediatric Pulmonology
Udgave nummer10
Sider (fra-til)3174-3182
StatusUdgivet - okt. 2021

Bibliografisk note

Funding Information:
Elsevier Language Editing Services was used for polishing the manuscript (Serial number: LE‐200009); this was funded by internal assets in the research group. We dedicate this paper to the children and families in the AD‐ON cohort. The Nordsjaellands Hospital Research Found and Children's Lung Foundation, Denmark, funded this follow‐up study.

Publisher Copyright:
© 2021 Wiley Periodicals LLC


Dyk ned i forskningsemnerne om 'Neonatal FeNO, risk factors, and respiratory morbidity in infants: A cohort study'. Sammen danner de et unikt fingeraftryk.